In a report released today, Joseph France from Cantor Fitzgerald reiterated a Hold rating on Cross Country Healthcare (NASDAQ: CCRN), with a price target of $10. The company’s shares opened today at $9.47.
France commented:
“CCRN is the smallest, but possibly the most-leveraged, public investment vehicle for capitalizing on the growing outsourcing of nurse staffing by large healthcare systems. Increased spending to support new contracts has weighed on results in recent periods, and we believe there could be continued weakness in nurse staffing volumes due to RN shortages and hospitals cutting contingent labor spending. We reiterate our Neutral rating on CCRN. $10 price target is based on a blend of our DCF and comparable-company analysis.”
According to TipRanks.com, France is a 5-star analyst with an average return of 11.5% and a 60.9% success rate. France covers the Services sector, focusing on stocks such as Five Star Quality Care, Envision Healthcare, and US Physical Therapy.
Currently, the analyst consensus on Cross Country Healthcare is a Moderate Buy with an average price target of $11.33.
See today’s analyst top recommended stocks >>
The company has a one-year high of $14.65 and a one-year low of $7.41. Currently, Cross Country Healthcare has an average volume of 327K.
Based on the recent corporate insider activity of 50 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of CCRN in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cross Country Healthcare, Inc. engages in the provision of healthcare staffing and workforce management solutions. It operates through the following segments: Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services.
